# FDA recall D-0773-2021

> **Eli Lilly & Company** · Class II · drug recall initiated 2021-08-19.

## Product

Trulicity (dulaglutide), 0.75 mg/0.5 mL, 4 Single-Dose Pens per box, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, NDC 0002-1433-80

## Reason for recall

Labeling: Label error on declared strength - autoinjector devices labeled as 0.75 mg / 0.5 mL actually contain 1.5 mg / 0.5 mL of product.

## Distribution

USA Nationwide

## Key facts

- **Recall number:** D-0773-2021
- **Recalling firm:** Eli Lilly & Company
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2021-08-19
- **Report date:** 2021-09-01
- **Termination date:** 2023-08-07

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Indianapolis, IN, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0773-2021

## Citation

> AI Analytics. FDA recall D-0773-2021. Retrieved 2026-07-17 from https://api.ai-analytics.org/recall/D-0773-2021. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*